A Modest Proposal: Prostate Biopsies and In-house Pathology Laboratories
David F. Penson, MD, MPH
Utilization Trends and Positive Biopsy Rates for Prostate Biopsies in the United States: 2005 to 2011
Deepak A. Kapoor, MD, David G. Bostwick, MD, MBA, Savvas E. Mendrinos, MD, Ann E. Anderson, MD, Carl A. Olsson, MD
The authors assess the positive biopsy rate and core sampling pattern in patients undergoing needle biopsy of the prostate in the United States at a national reference laboratory and anatomic pathology laboratories integrated into urology group practices, and analyze the relationship between positive biopsy rates and the number of specimen vials per biopsy.
Intracavitary Immunotherapy and Chemotherapy for Upper Urinary Tract Cancer: Current Evidence
Luca Carmignani, MD, Roberto Bianchi, MD, Gabriele Cozzi, MD, Angelica Grasso, MD, Nicola Macchione, MD, Carlo Marenghi, MD, Sara Melegari, MD, Marco Rosso, MD, Elena Tondelli, MD, Augusto Maggioni, MD
A review of the literature was performed to summarize current evidence about the efficacy of topical immunotherapy and chemotherapy for upper urinary tract urothelial cell carcinoma with regard to post-treatment recurrence rates.
The Use of In Vitro Fertilization in the Management of Male Infertility: What the Urologist Needs to Know
Sahar M. Stephens, MD, Daniel M. Arnett, MS, Randall B. Meacham, MD
The authors provide a brief overview of in vitro fertilization and intracytoplasmic sperm injection along with a discussion of the risks involved to facilitate the counseling and care of the infertile couple.
Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer
Vinay Prabhu,MD, MS, Ted Lee, BS, Tyler R. McClintock, BS, Herbert Lepor, MD
The primary aim of this comprehensive literature review is to examine short-, intermediate-, and long-term health-related quality of life following radical prostatectomy (RP). In addition, the long-term results of RP are compared with other treatment modalities for treating clinically localized prostate cancer.
Anesthetic Challenges in Robotic-assisted Urologic Surgery
Richard L. Hsu, MD, Alan D. Kaye, MD, PhD, Richard D. Urman, MD, MBA
Robotic-assisted surgery has evolved over the past two decades with constantly improving technology, assisting surgeons in multiple subspecialty disciplines. The surgical requirements of lithotomy and steep Trendelenburg positions, along with the creation of a pneumoperitoneum and limited access to the patient all present anesthetic management challenges in urologic surgery. Good communication among team members and knowledge of the nuances of robotic surgery have the potential to improve patient outcomes, increase efficiency, and reduce surgical and anesthetic complications.
Updates in the Care and Management of Prostate Cancer
Marnique Basto, Áine Goggins, Stacy Loeb, MD
This meeting included more than 1000 delegates from around the world. There were three parallel streams for clinical urology, translational science, nursing/allied health, and general practice, with a total of 174 abstract presentations.
47,XYY Syndrome and Male Infertility
Ina W. Kim, MD, MPH, Arjun C. Khadilkar, Edmund Y. Ko, MD, Edmund S. Sabanegh, Jr, MD
The authors review pertinent findings on physical examination and laboratory evaluation in three men diagnosed with 47,XYY during infertility evaluation and review the available literature on the subject, with special emphasis on fertility effects in men.
Splenogonadal Fusion: An Unusual Case of an Acute Scrotum
Rena D. Malik, MD, Dennis B. Liu, MD, FAAP, FACS
The authors highlight a case on a normal left testicle with a fibrovascular cord with three nodules consistent with splenic tissue. Splenogonadal fusion is a rather rare entity with approximately 184 cases reported in the literature.